NORMAL SITUATION

Apotheek De Sutter

Financial year 2024 · closed on 19/12/2024
Net result
-4,5 k €
-467.0% YoY
Gross margin
-4,7 k €
+20.5% YoY
Equity
1,1 M €
-0.4% YoY

Company — Normal situation.

What does Apotheek De Sutter do?

Apotheek De Sutter is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0418.419.396
Legal form
Private company with limited liability
Contributed capital
18 750,00 €
Latest accounts
19/12/2024
Signals
Solid equity
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 19 financial years

2024202320222021202020192018201720162015201420132012201120102009200820072006
Income statement
Gross margin-4,7 k €-5,9 k €-11,1 k €539,4 k €853,3 k €-21,2 k €-20,4 k €-15,6 k €-24,6 k €-37,3 k €-46,3 k €-27,7 k €-60,1 k €4 k €-53,9 k €17 k €10,3 k €30,3 k €-45,2 k €
EBITDA-5,1 k €-6,1 k €-11,6 k €525,5 k €801,8 k €-72,5 k €-85 k €-69,8 k €-24,8 k €-37,4 k €-46,4 k €-27,9 k €-60,3 k €-952,4 €-55,4 k €12,6 k €4,9 k €26,8 k €-49,2 k €
Operating result-5,1 k €-6,1 k €-11,6 k €525,5 k €798,1 k €-76,5 k €-89,3 k €-74,1 k €-28,5 k €-41,7 k €-50,8 k €-32,5 k €-65,4 k €-6,6 k €-57,4 k €10,4 k €-6,6 k €15,1 k €-60,7 k €
Net result-4,5 k €1,2 k €-4,9 k €386,8 k €706,4 k €-68,6 k €-89,9 k €-58,4 k €-12,9 k €-26,7 k €-36,4 k €-19 k €-51,2 k €-4,7 k €-47,1 k €14,9 k €9,8 k €21,3 k €-55,3 k €
Balance sheet
Equity1,1 M €1,1 M €1,1 M €1,1 M €693,3 k €-13,1 k €55,5 k €145,4 k €203,7 k €216,6 k €243,3 k €279,7 k €298,7 k €350 k €354,6 k €401,7 k €386,8 k €377 k €355,7 k €
Total assets1,1 M €1,1 M €1,2 M €1,4 M €1,4 M €442,8 k €369,7 k €390,6 k €396,6 k €344,2 k €326,7 k €329,2 k €322 k €395,3 k €388,4 k €442,9 k €429,1 k €415,9 k €389,4 k €
Cash285,6 k €532,8 k €855 k €109,6 k €55,3 k €18 k €4,3 k €11,3 k €5,4 k €687 €5 k €13,2 k €48,4 k €241,8 k €228,4 k €197,9 k €173,2 k €144,5 k €
Debts2,4 k €151,3 k €292,9 k €682,8 k €454,1 k €312,3 k €241,1 k €191,8 k €126,5 k €83,4 k €49,5 k €23,3 k €45,3 k €33,5 k €40,9 k €42 k €38,5 k €33,1 k €
Other
Workforce0,1 ETP0,8 ETP0,8 ETP0,8 ETP0,2 ETP0,2 ETP
Governance

Board of directors

Seen on filing of 19/12/2024 · 1 active · 7 ended

Active mandates

PharmaCross

Director · since 30 septembre 2017 · 0888.580.475

Represented by Danny Vander Cruyssen

Active

Ended mandates

PharmaCross

Manager · since 30 septembre 2017 · 0888.580.475

Represented by Danny Vander Cruyssen

Ended
PharmaCross

Director · since 30 septembre 2017 · 0888.580.475

Represented by Danny Vander Cruyssen

Ended
PharmaCross

Manager · since 30 septembre 2017 · 0888.580.475

Represented by Danny Vander Cruyssen

Ended
Charlotte De Sutter

Manager · since 01 janvier 2011 · 0831.893.774

Represented by Charlotte De Sutter

Ended
Annual accounts

Full financial information

202420232022202120202019
Type of accountMicro modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year19/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date24/01/202519/07/202403/07/202329/09/202230/08/202122/10/2020
General meeting19/12/202430/06/202430/06/202330/06/202230/06/202130/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

47 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model19/12/202419/12/202424/01/2025DutchPDF
Abridged model31/12/202330/06/202419/07/2024DutchPDF
Abridged model31/12/202230/06/202303/07/2023DutchPDF
Abridged model31/12/202130/06/202229/09/2022DutchPDF
Abridged model31/12/202030/06/202130/08/2021DutchPDF
Abridged model31/12/201930/06/202022/10/2020DutchPDF
Abridged model31/12/201830/06/201926/08/2019DutchPDF
Abridged model31/12/201730/06/201824/08/2018DutchPDF
Abridged model31/12/201630/06/201729/08/2017DutchPDF
Abridged model31/12/201530/06/201623/08/2016DutchPDF
Abridged model31/12/201430/06/201518/08/2015DutchPDF
Abridged model31/12/201330/06/201429/07/2014DutchPDF
Abridged model31/12/201230/06/201308/08/2013DutchPDF
Abridged model31/12/201130/06/201216/07/2012DutchPDF
Abridged model31/12/201030/06/201128/07/2011DutchPDF
Abridged model31/12/200930/06/201001/07/2010DutchPDF
Abridged model31/12/200830/06/200916/09/2009DutchPDF
Abridged model31/12/200730/06/200802/07/2008DutchPDF
Abridged model31/12/200630/06/200702/08/2007DutchPDF
Abridged model31/12/200530/06/200621/08/2006DutchPDF
Abridged model31/12/200430/06/200526/07/2005DutchPDF
Abridged model31/12/200330/07/200401/09/2004DutchPDF
Abridged model31/12/200230/06/200330/07/2003DutchPDF
Abridged model31/12/200130/08/200230/09/2002DutchPDF

View all 47 filings

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 19/12/2024 · 1 active · 7 ended

Active mandates

PharmaCross

Director · since 30 septembre 2017 · 0888.580.475

Represented by Danny Vander Cruyssen

Active

Ended mandates

PharmaCross

Manager · since 30 septembre 2017 · 0888.580.475

Represented by Danny Vander Cruyssen

Ended
PharmaCross

Director · since 30 septembre 2017 · 0888.580.475

Represented by Danny Vander Cruyssen

Ended
PharmaCross

Manager · since 30 septembre 2017 · 0888.580.475

Represented by Danny Vander Cruyssen

Ended
Charlotte De Sutter

Manager · since 01 janvier 2011 · 0831.893.774

Represented by Charlotte De Sutter

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Dissolution24/01/2025
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-4,5 k €
  2. 2023
    Annual accounts 20231,2 k €
  3. 2022
    Annual accounts 2022-4,9 k €
  4. 2021
    Annual accounts 2021386,8 k €
  5. 2020
    Annual accounts 2020706,4 k €
  6. 2019
    Annual accounts 2019-68,6 k €
  7. 2018
    Annual accounts 2018-89,9 k €
  8. 2017
    Annual accounts 2017-58,4 k €
  9. 2016
    Annual accounts 2016-12,9 k €
  10. 2015
    Annual accounts 2015-26,7 k €
  11. 2014
    Annual accounts 2014-36,4 k €
  12. 2013
    Annual accounts 2013-19 k €
  13. 2012
    Annual accounts 2012-51,2 k €
  14. 2011
    Annual accounts 2011-4,7 k €
  15. 2010
    Annual accounts 2010-47,1 k €
  16. 2009
    Annual accounts 200914,9 k €
  17. 2008
    Annual accounts 20089,8 k €
  18. 2007
    Annual accounts 200721,3 k €
  19. 2006
    Annual accounts 2006-55,3 k €